1-5 of 5
Jame Abraham
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

Avia D. Wilkerson, Prerana Bangalore Parthasarathy, Nickolas Stabellini, Carley Mitchell, Paul G. Pavicic, Jr, Pingfu Fu, Amit Rupani, Hana Husic, Patricia A. Rayman, Shadi Swaidani, Jame Abraham, G. Thomas Budd, Halle Moore, Zahraa Al-Hilli, Jennifer S. Ko, Joseph Baar, Timothy A. Chan, Tyler Alban, C. Marcela Diaz-Montero, Alberto J. Montero
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (1): 82–93.
https://doi.org/10.1158/1078-0432.CCR-23-1349
Published: 05 January 2024
View articletitled, Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer
Open the PDF for Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers

Nathaniel Braman, Prateek Prasanna, Kaustav Bera, Mehdi Alilou, Mohammadhadi Khorrami, Patrick Leo, Maryam Etesami, Manasa Vulchi, Paulette Turk, Amit Gupta, Prantesh Jain, Pingfu Fu, Nathan Pennell, Vamsidhar Velcheti, Jame Abraham, Donna Plecha, Anant Madabhushi
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (20): 4410–4424.
https://doi.org/10.1158/1078-0432.CCR-21-4148
Published: 14 October 2022
View articletitled, Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers
Open the PDF for Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers in another window
Includes: Supplementary data
Journal Articles

A Phase I Study of the P-Glycoprotein Antagonist Tariquidar in Combination with Vinorelbine

Jame Abraham, Maureen Edgerly, Richard Wilson, Clara Chen, Ann Rutt, Susan Bakke, Rob Robey, Andrew Dwyer, Barry Goldspiel, Frank Balis, Olaf Van Tellingen, Susan E. Bates, Tito Fojo
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (10): 3574–3582.
https://doi.org/10.1158/1078-0432.CCR-08-0938
Published: 18 May 2009
View articletitled, A Phase I Study of the P-Glycoprotein Antagonist Tariquidar in Combination with Vinorelbine
Open the PDF for A Phase I Study of the P-Glycoprotein Antagonist Tariquidar in Combination with Vinorelbine in another window
Includes: Supplementary data
Journal Articles

Population-Based Molecular Prognosis of Breast Cancer by Transcriptional Profiling

Yan Ma, Yong Qian, Liang Wei, Jame Abraham, Xianglin Shi, Vincent Castranova, E. James Harner, Daniel C. Flynn, Lan Guo
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (7): 2014–2022.
https://doi.org/10.1158/1078-0432.CCR-06-2222
Published: 02 April 2007
View articletitled, Population-Based Molecular Prognosis of Breast Cancer by Transcriptional Profiling
Open the PDF for Population-Based Molecular Prognosis of Breast Cancer by Transcriptional Profiling in another window
Includes: Supplementary data
Journal Articles

Increased 99mTc-Sestamibi Accumulation in Normal Liver and Drug-resistant Tumors after the Administration of the Glycoprotein Inhibitor, XR9576

Manish Agrawal, Jame Abraham, Frank M. Balis, Maureen Edgerly, Wilfred D. Stein, Susan Bates, Tito Fojo, Clara C. Chen
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (2): 650–656.
Published: 01 February 2003
View articletitled, Increased 99mTc-Sestamibi Accumulation in Normal Liver and Drug-resistant Tumors after the Administration of the Glycoprotein Inhibitor, XR9576
Open the PDF for Increased 99mTc-Sestamibi Accumulation in Normal Liver and Drug-resistant Tumors after the Administration of the Glycoprotein Inhibitor, XR9576 in another window